Compound 565
Identifiers
- Canonical SMILES:
Cc1ccc(cc1C)-c1nc(-c2nnnn2C)c(-c2cccc(Cl)c2)n1-c1cc(Cl)ccc1C
- InChi:
InChI=1S/C26H22Cl2N6/c1-15-8-10-19(12-17(15)3)25-29-23(26-30-31-32-33(26)4)24(18-6-5-7-20(27)13-18)34(25)22-14-21(28)11-9-16(22)2/h5-14H,1-4H3
- InChiKey:
CFBOWKGRGWQTLK-UHFFFAOYSA-N
External links
67031837 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 4.87 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 488.13 g/mol | |||
HBA | 6 | |||
HBD | 0 | |||
HBA + HBD | 6 | |||
AlogP | 7.14 | |||
TPSA | 61.42 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011023677 | 21 | MDM2 Q00987 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 4.87 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4583 | Azeliragon | DB12689 | |
0.4220 | Cimicoxib | DB05095 | |
0.4160 | Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB03084 | |
0.4135 | TAS-117 | DB15054 | |
0.4125 | Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB02388 | |
0.4091 | Losartan | DB00678 | |
0.4035 | Miransertib | DB14982 | |
0.3917 | N-6022 | DB12206 | |
0.3846 | Ralimetinib | DB11787 | |
0.3843 | 4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine | DB01761 | |
0.3843 | 4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine | DB08076 | |
0.3826 | Olmesartan | DB00275 | |
0.3745 | Radotinib | DB12323 | |
0.3706 | ONT-093 | DB14069 | |
0.3695 | 4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE | DB07607 |